ImageneBio, Inc. (IMA)
NASDAQ · Healthcare
ImageneBio, Inc. Revenue 2020–2025
ImageneBio, Inc. annual/quarterly revenue history and growth rate from 2020 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- ImageneBio, Inc. revenue for the quarter ending September 30, 2025 was 0, a 100.00% decrease year-over-year.
- ImageneBio, Inc. revenue for the twelve months ending September 30, 2025 was 5.5 M, a 61.10% decrease year-over-year.
- ImageneBio, Inc. annual revenue for 2025 was 800000, a 77.14% decrease from 2024.
- ImageneBio, Inc. annual revenue for 2024 was 3.5 M, a 61.79% decrease from 2023.
- ImageneBio, Inc. annual revenue for 2023 was 9.2 M, a 41.35% decrease from 2022.
- ImageneBio, Inc. annual revenue for 2022 was 15.6 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
ImageneBio, Inc. (IMA) — Frequently Asked Questions
ImageneBio, Inc. (IMA) is a publicly traded US company. In fiscal 2025 it reported revenue of $800,000 and net income of -$45M. Explore IMA's stock price, financial statements, earnings history, margins and key ratios below.
What is the IMA stock price?
IMA trades at $5.51 (-0.72% on the day).
How much revenue does ImageneBio, Inc. make?
ImageneBio, Inc. reported revenue of $800,000 in fiscal 2025.
Is IMA profitable?
In fiscal 2025, ImageneBio, Inc. reported net income of -$45M.